Deutsche Bank Ag\ Rapt Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 274,832 shares of RAPT stock, worth $2.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

274,832

Previous 276,170 0.48%

Holding current value

$2.32 Million

Previous $436,000 23.17%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$1.05 - $1.72 $1,404 - $2,301	-1,338 Reduced 0.48%	274,832 $335,000
Q4 2024 Feb 14, 2025	SELL	$0.81 - $3.1 $7,515 - $28,764	-9,279 Reduced 3.25%	276,170 $436,000
Q3 2024 Jun 26, 2025	BUY	$1.76 - $3.75 $18,685 - $39,813	10,617 Added 3.86%	285,449 $573,000
Q3 2024 Nov 13, 2024	SELL	$1.76 - $3.75 $1.14 Million - $2.43 Million	-647,092 Reduced 69.39%	285,449 $573,000
Q2 2024 Jun 12, 2025	BUY	$2.89 - $9.38 $1.9 Million - $6.17 Million	657,709 Added 239.31%	932,541 $2.84 Million
Q2 2024 Aug 14, 2024	BUY	$2.89 - $9.38 $1.86 Million - $6.03 Million	643,031 Added 222.11%	932,541 $2.84 Million
Q1 2024 Jun 02, 2025	BUY	$6.87 - $26.45 $100,837 - $388,233	14,678 Added 5.34%	289,510 $2.6 Million
Q1 2024 May 15, 2024	SELL	$6.87 - $26.45 $4,383 - $16,875	-638 Reduced 0.22%	289,510 $2.6 Million
Q4 2023 Feb 14, 2024	BUY	$11.28 - $25.46 $3.1 Million - $6.99 Million	274,559 Added 1761.24%	290,148 $7.21 Million
Q3 2023 Nov 09, 2023	SELL	$16.34 - $24.66 $4.46 Million - $6.73 Million	-272,846 Reduced 94.6%	15,589 $259,000
Q2 2023 Aug 14, 2023	SELL	$16.06 - $21.61 $119,791 - $161,188	-7,459 Reduced 2.52%	288,435 $5.39 Million
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $167,705 - $300,484	9,756 Added 3.41%	295,894 $5.43 Million
Q4 2022 Feb 13, 2023	BUY	$16.28 - $24.6 $2,800 - $4,231	172 Added 0.06%	286,138 $5.67 Million
Q3 2022 Nov 14, 2022	SELL	$17.96 - $30.46 $56,538 - $95,888	-3,148 Reduced 1.09%	285,966 $6.88 Million
Q2 2022 Aug 11, 2022	BUY	$10.26 - $23.59 $7,982 - $18,353	778 Added 0.27%	289,114 $5.28 Million
Q1 2022 May 13, 2022	SELL	$17.02 - $40.22 $399,884 - $944,968	-23,495 Reduced 7.53%	288,336 $6.34 Million
Q4 2021 Feb 11, 2022	BUY	$29.5 - $39.5 $8.76 Million - $11.7 Million	297,038 Added 2007.96%	311,831 $11.5 Million
Q3 2021 Nov 04, 2021	BUY	$29.86 - $39.47 $61,183 - $80,874	2,049 Added 16.08%	14,793 $460,000
Q2 2021 Aug 11, 2021	SELL	$17.99 - $40.02 $1.01 Million - $2.25 Million	-56,213 Reduced 81.52%	12,744 $405,000
Q1 2021 May 13, 2021	BUY	$16.0 - $24.46 $722,736 - $1.1 Million	45,171 Added 189.91%	68,957 $1.53 Million
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $281,125 - $723,072	17,692 Added 290.32%	23,786 $470,000
Q3 2020 Nov 12, 2020	BUY	$21.6 - $37.5 $11,534 - $20,025	534 Added 9.6%	6,094 $196,000
Q2 2020 Aug 13, 2020	BUY	$14.16 - $32.85 $71,777 - $166,516	5,069 Added 1032.38%	5,560 $162,000
Q1 2020 May 14, 2020	SELL	$11.86 - $48.86 $355 - $1,465	-30 Reduced 5.76%	491 $10,000
Q4 2019 Feb 14, 2020	BUY	$12.3 - $30.78 $6,408 - $16,036	521 New	521 $14,000

Others Institutions Holding RAPT

# of Institutions

100

Shares Held

134M

Call Options Held

41.3K

Put Options Held

100

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $250M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account